ロード中...

Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway

PURPOSE: The options for treating lung cancers are limited, as diagnosis typically occurs during the late stages of the disease. There is a dire need to develop aPKC (atypical Protein Kinase C) inhibitors due to aPKC overexpression and contributions to lung cancer malignancies. In this study, we inv...

詳細記述

保存先:
書誌詳細
出版年:Onco Targets Ther
主要な著者: BommaReddy, Raja Reddy, Patel, Rekha, Smalley, Tracess, Acevedo-Duncan, Mildred
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7047975/
https://ncbi.nlm.nih.gov/pubmed/32158232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S224866
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!